Global Deferasirox Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published On: June 2018
 
Report ID:259242
 
 
Pages: 111




Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.

Scope of the Report:

This report focuses on the Deferasirox in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be taken orally unlike deferoxamine which has to be administered by IV route (intravenous infusion). Together with deferiprone, deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood. Consumers are generally quick-change, to get or use newfangled products, better experience, better convenience and more quicker; to find and meet the needs of consumers, and exceeding expectation, better service.

The worldwide market for Deferasirox is expected to grow at a CAGR of roughly 4.7% over the next five years, will reach 2990 million US$ in 2023, from 2270 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Novartis

Cipla

Sun Pharma

Natco Pharma

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

500 mg/Tablet

250 mg/Tablet

125 mg/Tablet

Others

Market Segment by Applications, can be divided into

Transfusional Iron Overload

NTDT Caused Iron Overload

There are 15 Chapters to deeply display the global Deferasirox market.

Chapter 1, to describe Deferasirox Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Deferasirox, with sales, revenue, and price of Deferasirox, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Deferasirox, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Deferasirox market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Deferasirox sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Deferasirox Introduction

1.2 Market Analysis by Type

1.2.1 500 mg/Tablet

1.2.2 250 mg/Tablet

1.2.3 125 mg/Tablet

1.2.4 Others

1.3 Market Analysis by Applications

1.3.1 Transfusional Iron Overload

1.3.2 NTDT Caused Iron Overload

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Novartis

2.1.1 Business Overview

2.1.2 Deferasirox Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Novartis Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Cipla

2.2.1 Business Overview

2.2.2 Deferasirox Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Cipla Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sun Pharma

2.3.1 Business Overview

2.3.2 Deferasirox Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sun Pharma Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Natco Pharma

2.4.1 Business Overview

2.4.2 Deferasirox Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Natco Pharma Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Deferasirox Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Deferasirox Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Deferasirox Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Deferasirox Manufacturer Market Share in 2017

3.3.2 Top 6 Deferasirox Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Deferasirox Market Analysis by Regions

4.1 Global Deferasirox Sales, Revenue and Market Share by Regions

4.1.1 Global Deferasirox Sales and Market Share by Regions (2013-2018)

4.1.2 Global Deferasirox Revenue and Market Share by Regions (2013-2018)

4.2 North America Deferasirox Sales and Growth Rate (2013-2018)

4.3 Europe Deferasirox Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Deferasirox Sales and Growth Rate (2013-2018)

4.5 South America Deferasirox Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Deferasirox Sales and Growth Rate (2013-2018)

5 North America Deferasirox by Countries

5.1 North America Deferasirox Sales, Revenue and Market Share by Countries

5.1.1 North America Deferasirox Sales and Market Share by Countries (2013-2018)

5.1.2 North America Deferasirox Revenue and Market Share by Countries (2013-2018)

5.2 United States Deferasirox Sales and Growth Rate (2013-2018)

5.3 Canada Deferasirox Sales and Growth Rate (2013-2018)

5.4 Mexico Deferasirox Sales and Growth Rate (2013-2018)

6 Europe Deferasirox by Countries

6.1 Europe Deferasirox Sales, Revenue and Market Share by Countries

6.1.1 Europe Deferasirox Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Deferasirox Revenue and Market Share by Countries (2013-2018)

6.2 Germany Deferasirox Sales and Growth Rate (2013-2018)

6.3 UK Deferasirox Sales and Growth Rate (2013-2018)

6.4 France Deferasirox Sales and Growth Rate (2013-2018)

6.5 Russia Deferasirox Sales and Growth Rate (2013-2018)

6.6 Italy Deferasirox Sales and Growth Rate (2013-2018)

7 Asia-Pacific Deferasirox by Countries

7.1 Asia-Pacific Deferasirox Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Deferasirox Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Deferasirox Revenue and Market Share by Countries (2013-2018)

7.2 China Deferasirox Sales and Growth Rate (2013-2018)

7.3 Japan Deferasirox Sales and Growth Rate (2013-2018)

7.4 Korea Deferasirox Sales and Growth Rate (2013-2018)

7.5 India Deferasirox Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Deferasirox Sales and Growth Rate (2013-2018)

8 South America Deferasirox by Countries

8.1 South America Deferasirox Sales, Revenue and Market Share by Countries

8.1.1 South America Deferasirox Sales and Market Share by Countries (2013-2018)

8.1.2 South America Deferasirox Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Deferasirox Sales and Growth Rate (2013-2018)

8.3 Argentina Deferasirox Sales and Growth Rate (2013-2018)

8.4 Colombia Deferasirox Sales and Growth Rate (2013-2018)

9 Middle East and Africa Deferasirox by Countries

9.1 Middle East and Africa Deferasirox Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Deferasirox Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Deferasirox Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Deferasirox Sales and Growth Rate (2013-2018)

9.3 UAE Deferasirox Sales and Growth Rate (2013-2018)

9.4 Egypt Deferasirox Sales and Growth Rate (2013-2018)

9.5 Nigeria Deferasirox Sales and Growth Rate (2013-2018)

9.6 South Africa Deferasirox Sales and Growth Rate (2013-2018)

10 Global Deferasirox Market Segment by Type

10.1 Global Deferasirox Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Deferasirox Sales and Market Share by Type (2013-2018)

10.1.2 Global Deferasirox Revenue and Market Share by Type (2013-2018)

10.2 500 mg/Tablet Sales Growth and Price

10.2.1 Global 500 mg/Tablet Sales Growth (2013-2018)

10.2.2 Global 500 mg/Tablet Price (2013-2018)

10.3 250 mg/Tablet Sales Growth and Price

10.3.1 Global 250 mg/Tablet Sales Growth (2013-2018)

10.3.2 Global 250 mg/Tablet Price (2013-2018)

10.4 125 mg/Tablet Sales Growth and Price

10.4.1 Global 125 mg/Tablet Sales Growth (2013-2018)

10.4.2 Global 125 mg/Tablet Price (2013-2018)

10.5 Others Sales Growth and Price

10.5.1 Global Others Sales Growth (2013-2018)

10.5.2 Global Others Price (2013-2018)

11 Global Deferasirox Market Segment by Application

11.1 Global Deferasirox Sales Market Share by Application (2013-2018)

11.2 Transfusional Iron Overload Sales Growth (2013-2018)

11.3 NTDT Caused Iron Overload Sales Growth (2013-2018)

12 Deferasirox Market Forecast (2018-2023)

12.1 Global Deferasirox Sales, Revenue and Growth Rate (2018-2023)

12.2 Deferasirox Market Forecast by Regions (2018-2023)

12.2.1 North America Deferasirox Market Forecast (2018-2023)

12.2.2 Europe Deferasirox Market Forecast (2018-2023)

12.2.3 Asia-Pacific Deferasirox Market Forecast (2018-2023)

12.2.4 South America Deferasirox Market Forecast (2018-2023)

12.2.5 Middle East and Africa Deferasirox Market Forecast (2018-2023)

12.3 Deferasirox Market Forecast by Type (2018-2023)

12.3.1 Global Deferasirox Sales Forecast by Type (2018-2023)

12.3.2 Global Deferasirox Market Share Forecast by Type (2018-2023)

12.4 Deferasirox Market Forecast by Application (2018-2023)

12.4.1 Global Deferasirox Sales Forecast by Application (2018-2023)

12.4.2 Global Deferasirox Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source






Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.